Join us as our CEO and Founder, Nick Mercadante, will highlight innovation, access, and human impact in behavioral health. San Diego, CA—November 5, 2025—PursueCare, a leader in virtual addiction and behavioral health treatment, announced today its sponsorship of the Behavioral Health Tech (BHT) Conference 2025,...

PursueCare is pleased to announce the promotion of Jason Kirby, DO, MBA, DFASAM to Chief Medical Officer (CMO). Dr. Kirby will lead a focused plan to strengthen clinical practices, outcomes, and programs. He will oversee our Medical Providers, Medical Directors, and Clinical Directors as well...

Dr. Jason Kirby, DO, MBA, DFASAM is schedule to be a session presenter at OMED25. Be sure to register today to attend his session and explore many others. Dr. Kirby is looking forward to aligning leadership, education, and patient care while connecting with DOs, residents,...

And How PursueCare Can Help Recently, the FDA has pushed for 7-OH Mitragynine, a high-potency form of Kratom sold in head shops, to be classified as a Schedule I substance. If approved, possession of this substance will become illegal, and many individuals dependent on it...